---
document_datetime: 2023-09-21 19:12:00
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/exalief-epar-all-authorised-presentations_en.pdf
document_name: exalief-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.2688053
conversion_datetime: 2025-12-25 08:57:46.897808
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number                 | Invented name   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging         | Package size          |
|---------------------------|-----------------|------------|-----------------------|---------------------------|-------------------|-----------------------|
| EU/1/09/520/001           | Exalief         | 400 mg     | Tablet                | Oral use                  | blister (alu/alu) | 7 tablets             |
| EU/1/09/520/002           | Exalief         | 400 mg     | Tablet                | Oral use                  | blister (alu/alu) | 14 tablets authorised |
| EU/1/09/520/003           | Exalief         | 400 mg     | Tablet                | Oral use                  | blister (alu/alu) | 28 tablets            |
| EU/1/09/520/004           | Exalief         | 400 mg     | Tablet                | Oral use                  | blister (PVC/alu) | 7 tablets             |
| EU/1/09/520/005           | Exalief         | 400 mg     | Tablet                | Oral use                  | blister (PVC/alu) | 14 tablets            |
| EU/1/09/520/006           | Exalief         | 400 mg     | Tablet                | Oral use                  | blister (PVC/alu) | 28 tablets            |
| EU/1/09/520/007           | Exalief         | 600 mg     | Tablet                | Oral use                  | blister (alu/alu) | 30 tablets            |
| EU/1/09/520/008           | Exalief         | 600 mg     | Tablet                | Oral use                  | blister (alu/alu) | 60 tablets            |
| EU/1/09/520/009           | Exalief         | 600 mg     | Tablet                | Oral use                  | blister (PVC/alu) | 30 tablets            |
| EU/1/09/520/010           | Exalief         | 600 mg     | Tablet                | Oral use longer           | blister (PVC/alu) | 60 tablets            |
| EU/1/09/520/011           | Exalief         | 600 mg     | Tablet                | Oral use                  | bottle (HDPE)     | 90 tablets            |
| EU/1/09/520/012           | Exalief         | 800 mg     | Tablet                | Oral use                  | blister (alu/alu) | 20 tablets            |
| EU/1/09/520/013           | Exalief         | 800 mg     | Tablet                | Oral use no               | blister (alu/alu) | 30 tablets            |
| EU/1/09/520/014           | Exalief         | 800 mg     | Tablet                | Oral use                  | blister (alu/alu) | 60 tablets            |
| EU/1/09/520/015           | Exalief         | 800 mg     | Tablet                | Oral use                  | blister (alu/alu) | 90 tablets            |
| EU/1/09/520/016           | Exalief         | 800 mg     | Tablet product        | Oral use                  | blister (PVC/alu) | 20 tablets            |
| EU/1/09/520/017           | Exalief         | 800 mg     | Tablet                | Oral use                  | blister (PVC/alu) | 30 tablets            |
| EU/1/09/520/018           | Exalief         | 800 mg     | Tablet                | Oral use                  | blister (PVC/alu) | 60 tablets            |
| EU/1/09/520/019           | Exalief         | 800 mg     | Tablet                | Oral use                  | blister (PVC/alu) | 90 tablets            |
| EU/1/09/520/020 Medicinal | Exalief         | 800 mg     | Tablet                | Oral use                  | bottle (HDPE)     | 90 tablets            |